CASI
CASI Pharmaceuticals, Inc.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K | 6/29/2026 | View on SEC |
| 25-NSE | 6/23/2026 | View on SEC |
| 6-K | 6/2/2026 | View on SEC |
| SCHEDULE 13D/A | 5/18/2026 | View on SEC |
| 20-F | 5/15/2026 | View on SEC |
| D | 4/28/2026 | View on SEC |
| 3 | 4/23/2026 | View on SEC |
| NT 20-F | 4/21/2026 | View on SEC |
| 3 | 4/20/2026 | View on SEC |
| 6-K | 4/20/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CASI |
| Company Name | CASI Pharmaceuticals, Inc. |
| CIK | 1962738 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | E9 |
| Phone | 86 10 6561 8789 |